| Analysis | Metabolite Name | Measured Value | Units | Days post-STZ |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)- | 15160 | Peak area | - |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)- | 16523 | Peak area | - |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)- | 17242 | Peak area | 3 |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)- | 18886 | Peak area | 30 |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)- | 22324 | Peak area | 3 |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)- | 27224 | Peak area | 3 |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)- | 49355 | Peak area | 30 |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)- | 53701 | Peak area | 30 |
| Reversed phase NEGATIVE ION MODE | DEOXYADENOSINE (CAS# 16373-93-6); (M+CL)- | Peak area | - |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|